ELS-tíðindi - nóvember 2000

74 ELS tíðindi 11/2000
(21) 5696
(22) 31.10.2000
(51) C12N; C07K; A61K
(54) Mótefni gegn CD23, afleiður þeirra
og meðferðarnotkun þeirra.
(71) Glaxo Group Limited, Glaxo
Wellcome House, Berkeley Avenue,
Greenford, Middlesex, UB6 ONN,
Bretlandi.
(72) Jean-Yves Marcel Paul Bonnefoy,
Saint-Julien-en-Genevois, Cedex,
Frakklandi; Scott James Crowe,
Stevenage, Hertfordshire, Bretlandi;
Jonathan Henry Ellis, Stevenage,
Hertfordshire, Bretlandi; Nicholas
Timothy Rapson, Stevenage,
Hertfordshire, Bretlandi; Jean
Shearin, Research Triangle Park,
North Carolina, Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 9.5.98, GB, 9809839.5
(85) 31.10.2000
(86) 7.5.99, PCT/GB99/01434
(21) 5697
(22) 31.10.2000
(51) C12N; C07K
(54) Uppleysanlegur T-eitilfrumu viðtaki.
(71) Avidex Limited, 57C Milton Park,
Milton, Oxon, OX14 4RX, Bretlandi.
(72) Bent Karsten Jakobsen, Milton,
Oxon, Bretlandi; Jonathan Michael
Boulter, Milton, Oxon, Bretlandi; John
Irving Bell, Oxford, Oxfordshire,
Bretlandi; George Fu Gao, Boston,
Massachusetts, Bandaríkjunum;
Benjamin Ernest Willcox, Pasadena,
California, Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 19.5.98, GB, 9810759.2
29.9.98, GB, 9821129.5
(85) 31.10.2000
(86) 19.5.99, PCT/GB99/01588